We are live on
!
Find out more
HF
HRT Financial Portfolio holdings
AUM
$40.1B
1-Year Est. Return
58.22%
This Fund
S&P 500
This Quarter
Est. Return
+23.15%
1 Year Est. Return
+58.22%
3 Year Est. Return
+133.11%
5 Year Est. Return
+158.39%
10 Year Est. Return
+582.81%
AUM
$27.2B
AUM Growth
+$4.48B
(+20%)
Cap. Flow
+$2.05B
Cap. Flow
% of AUM
7.53%
Top 10 Holdings %
Top 10 Hldgs %
39.03%
Holding
3,928
New
1,420
Increased
825
Reduced
534
Closed
1,145
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$599M |
| 2 |
NVIDIA
NVDA
|
+$586M |
| 3 |
Microsoft
MSFT
|
+$285M |
| 4 |
Amphenol
APH
|
+$191M |
| 5 |
Johnson & Johnson
JNJ
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$727M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$441M |
| 3 |
Palantir
PLTR
|
+$307M |
| 4 |
Thomson Reuters
TRI
|
+$279M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$262M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.7% |
| 2 | Financials | 7% |
| 3 | Healthcare | 5.22% |
| 4 | Industrials | 4.77% |
| 5 | Consumer Discretionary | 4.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TWAV
2676
TaoWeave Inc
TWAV
$4.42M
| $26K | ﹤0.01% |
+10,334
| New | +$37K |
|
2677
Xtant Medical Holdings
XTNT
$62.3M
| $26K | ﹤0.01% |
+40,803
| New | +$25.7K |
|
|
TGE
2678
The Generation Essentials Group
TGE
$45.8M
| $26K | ﹤0.01% |
12,552
-3,265
| -21% | -$13.9K |
|
|
BRNS
2679
Barinthus Biotherapeutics
BRNS
$24.5M
| $25K | ﹤0.01% |
+20,152
| New | +$25.2K |
|
2680
IGC Pharma
IGC
$26.8M
| $25K | ﹤0.01% |
+60,258
| New | +$22.9K |
|
2681
Pulmonx
LUNG
$87.6M
| $25K | ﹤0.01% |
+15,436
| New | +$32.3K |
|
|
AACG
2682
ATA Creativity
AACG
$37.2M
| $24K | ﹤0.01% |
+17,735
| New | +$28.8K |
|
|
FORA
2683
DELISTED
Forian
FORA
| $24K | ﹤0.01% |
+10,872
| New | +$22.2K |
|
2684
Prelude Therapeutics
PRLD
$390M
| $24K | ﹤0.01% |
+16,901
| New | +$16.9K |
|
2685
FibroBiologics
FBLG
$6.5M
| $24K | ﹤0.01% |
2,207
+317
| +17% | +$3.8K |
|
|
NTCL
2686
NetClass Technology Inc
NTCL
$3.75M
| $24K | ﹤0.01% |
+337
| New | +$28.9K |
|
|
APUS
2687
Apimeds Pharmaceuticals US
APUS
$6.38M
| $24K | ﹤0.01% |
+1,357
| New | +$25.1K |
|
2688
Acumen Pharmaceuticals
ABOS
$176M
| $23K | ﹤0.01% |
14,014
-17,413
| -55% | -$24.1K |
|
2689
Global Mofy Metaverse
GMM
$5.72M
| $23K | ﹤0.01% |
+239
| New | +$28.8K |
|
|
TBHC
2690
DELISTED
The Brand House Collective
TBHC
| $23K | ﹤0.01% |
+14,570
| New | +$22.1K |
|
2691
TRX Gold Corp
TRX
$344M
| $23K | ﹤0.01% |
+37,000
| New | +$14.9K |
|
2692
Traws Pharma
TRAW
$8.1M
| $23K | ﹤0.01% |
+12,573
| New | +$20.5K |
|
|
WFF
2693
WF Holding Ltd
WFF
$20.9M
| $23K | ﹤0.01% |
+5,216
| New | +$28.1K |
|
|
KUKE
2694
DELISTED
Kuke Music
KUKE
| $22K | ﹤0.01% |
+38,767
| New | +$79.2K |
|
2695
Ostin Technology Group
OST
| $22K | ﹤0.01% |
+13,551
| New | +$32.1K |
|
2696
Elutia
ELUT
$37.6M
| $21K | ﹤0.01% |
+24,228
| New | +$44.9K |
|
|
GELS
2697
Gelteq Ltd
GELS
$5.98M
| $21K | ﹤0.01% |
15,439
-29,180
| -65% | -$45.3K |
|
|
PCLA
2698
PicoCELA Inc
PCLA
$78M
| $21K | ﹤0.01% |
1,604
-3,790
| -70% | -$89.2K |
|
|
BGFV
2699
DELISTED
Big 5 Sporting Goods
BGFV
| $20K | ﹤0.01% |
14,445
-2,058
| -12% | -$2.92K |
|
2700
MMTec
MTC
$299M
| $20K | ﹤0.01% |
+24,904
| New | +$23.4K |
|
Similar funds
DB
HRT Financial's Q3 2025 Portfolio in Review
As of Q3 2025, HRT Financial held 3,928 positions worth $27.2B, up 20% from $22.7B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
HRT Financial deployed $2.05B of net new capital in Q3 2025, opening 1,420 new positions and adding to 825 existing holdings. Its largest new stake was NVIDIA: 3,361,930 shares worth $627M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 6.9% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $441M trimmed.
- HRT Financial's largest Q3 2025 buy was NVIDIA: 3,361,930 shares worth $627M.
- HRT Financial added most to Apple in Q3 2025, an estimated $599M increase.
- HRT Financial's biggest Q3 2025 reduction was Invesco QQQ Trust, cutting an estimated $441M.
- HRT Financial fully exited Applovin in Q3 2025, selling an estimated $727M.
- HRT Financial's ten largest holdings make up 39% of its $27.2B portfolio in Q3 2025.
- HRT Financial opened 1,420 new positions and closed 1,145 in Q3 2025.
- HRT Financial's portfolio value rose 20% quarter-over-quarter to $27.2B.
Based on HRT Financial's 13F filing for Q3 2025, filed 14 Nov 2025.